Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132969) titled 'Study to Evaluate Whether Shenfu Injection Can Improve Outcomes in Patients with Septic Shock' on Sept. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The first affiliated hospital of anhui medical university
Condition:
septic shock
Intervention:
Shenfu Injection Treatment Group:On the basis of conventional treatment, Shenfu Injection is administered at the recommended dose of 100 mL of Shenfu Injection added to 250 mL of 0.9% sodium chloride injection, by intravenous infusion, once daily for 5 consecutive days.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First...